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LETTERS TO THE EDITOR
What Is the Mechanism of Abnormal
Blood Pressure Response on
Exercise in Hypertrophic Cardiomyopathy?
Ciampi et al. (1) recently reported a study on the mechanism of
abnormal blood pressure response (ABPR) on exercise in hyper-
trophic cardiomyopathy (HCM). Their study suggests that ABPR
is due to a profound impairment of cardiac output augmentation
on exercise. Cardiac output was measured using a portable nuclear
detector (nuclear VEST). Their results are in marked contrast to
two previous published studies carried out by us.
In the first study Frenneaux et al. (2) evaluated cardiac output
changes invasively and showed that ABPR was due to an exag-
gerated fall in systemic vascular resistance rather than a failure of
cardiac output to increase appropriately. In the second study we
showed that in patients with ABPR there was vasodilation in
nonexercising vascular beds instead of the “normal” vasoconstrictor
response (3). In the study by Ciampi et al. (1) we note that in all
three groups of subjects (healthy controls, HCM, and ABPR
HCM) cardiac output responses to exercise are markedly lower
than would be expected from the published data. Furthermore, the
HCM patients with ABPR have only marginally lower exercise
duration than do subjects with a normal blood pressure response.
Yet, in contrast, these patients demonstrate a dramatically lower
cardiac output response.
The group with ABPR performed 8 min of exercise on a Bruce
protocol. This should equate to a VO2 peak of approximately 20 to
25 ml/kg/min, which is similar to the measurement we have
observed in an analogous group of patients with ABPR. In
contrast, the observed increase in cardiac output of only 50% would
be anticipated to lead to a VO2 peak of only 9 to 10 ml/kg/min. We
should comment that we have tested the nuclear VEST technique
for measuring cardiac output changes during exercise. The values
we obtained were implausibly low, and we therefore abandoned the
technique.
To the best of our knowledge, cardiac output measurements
during exercise using the cardiac VEST technique have not been
validated against established invasive measurements. Moreover, to
ensure that the VEST was correctly positioned over the left
ventricle (LV), the VEST detector was placed under gamma
camera control with a 30-s static imaging obtained at the end of
exercise (1). These control measures, however, were made in the
supine position. Because exercise was performed in the upright
posture, it is quite likely that some degree of displacement of the
VEST relative to the LV took place. Although we greatly respect
the work of this group, we suggest that the nuclear VEST cardiac
data are incompatible with the observed exercise duration of these
patients and that this must be due to an inherent inaccuracy of the
technique during exercise, as used by both Ciampi et al. (1) and
ourselves. Furthermore, given the very similar treadmill exercise
duration of the HCM patients with and without ABPR, the
hugely different cardiac output responses are unlikely to be valid.
These observations suggest that the technique cannot even be used
for the assessment of qualitative rather than quantitative differ-
ences.
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REPLY
We read with great interest Dr. Campbell’s letter. His points rely
basically on one statement and two syllogisms. The statement is
that the VEST technique is inadequate in measuring cardiac
hemodynamics. The syllogisms are that, hence, our findings (1) are
inaccurate and, thus, their conclusions (2,3) are correct. We will try
to dispute the statement and the first syllogism.
As for the statement, various studies have evaluated the accuracy
and the reproducibility of measurements obtained by VEST (4–7).
In our laboratory, Pace et al. (8) demonstrated that the VEST-
derived values of ejection fraction and peak filling rate are accurate
and repeatable (8). Imbriaco et al. (9) showed that VEST is
accurate in measuring cardiac hemodynamic responses to different
cardiac stimulations (handgrip, tilt test, and nitrate administra-
tion). The researchers measured changes from baseline to peak
response in ejection fraction, stroke volume, and cardiac output,
and they found that these changes are similar in two different
studies (coefficient of repeatability: 7.0, 7.0, and 7.6, respectively).
Dr. Campbell is correct in saying that a validation of VEST-
measured cardiac output in comparison with invasive techniques
has never been performed; this is not crucial, though. The
VEST does not measure absolute cardiac output; rather, it
measures changes relative to baseline, and these changes are
reproducible (9). In addition, measurements are derived from
counts and are geometry-independent; therefore, exercise-
induced changes in left ventricular (LV) shape would not affect
the accuracy of measurements.
Second, VEST monitoring has also been used by others to
assess LV function changes during routine activities and could
detect silent ischemic episodes (10–12). Follow-up demonstrated a
highly significant relationship between the occurrence of silent LV
dysfunction, assessed by VEST, and cardiac events (13,14). Kay-
den et al. (15) monitored LV systolic function by VEST during left
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